Neogambogic acid osmotic pump type sustained-release preparation and preparation method thereof
A new technology of gambogic acid and controlled-release preparations, which is applied in pharmaceutical formulations, medical preparations containing active ingredients, drug delivery, etc. Realize the problems of industrialized production, low drug release efficiency, etc., to achieve stable and effective blood drug concentration, prolong the blood drug concentration time, and reduce the number of times of drug administration.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0059] Experiment 1 Preparation of new gambogic acid osmotic pump
[0060] Preparation process and influencing factors of new gambogic acid osmotic pump tablets
[0061] 1.1 Preparation process
[0062] Tablet core: pass new gambogic acid, PEO-N10, lactose, sodium chloride, L-arginine through 80-mesh sieve, weigh according to the prescription amount, mix by equal addition method, add 95% ethanol solution to make soft material, Granulate with a 20-mesh sieve, dry at 40°C for 6 hours, add an appropriate amount of magnesium stearate and mix well.
[0063] Preparation of coating solution: Weigh the prescribed amount of cellulose acetate and dissolve it in acetone to prepare a certain concentration of cellulose acetate acetone solution, add a certain amount of dibutyl phthalate DBP and PEG4000, and place on a magnetic stirrer Stir without heating until the solution is completely dissolved.
[0064] Tablet compression and coating: install the upper and lower punches, adjust the t...
Embodiment 1
[0202] Tablet core prescription (based on 200mg per tablet, based on the weight of the controlled-release semipermeable coating film accounting for 2% of the weight of the tablet core, the weight of the tablet core is about 196mg, and the weight of the film is about 4mg)
[0203]
[0204] Prescription of semipermeable film coating solution:
[0205] Cellulose acetate 15mg
[0206] Diethyl phthalate 10mg
[0207] PEG4000 30mg
[0208] Preparation process: pass the above-mentioned new gambogic acid and auxiliary materials (other auxiliary materials except magnesium stearate) according to the prescription amount through a 100-mesh sieve, mix well, use 95% ethanol solution to make a soft material, and pass through a 24-mesh sieve to granulate , dried at 40°C, passed through a 24-mesh sieve for granulation, added the prescribed amount of magnesium stearate, mixed evenly, compressed into tablets, and the pressure was controlled at 60N to obtain tablet cores. Dissolve the above...
Embodiment 2
[0210] Tablet core prescription (based on 200mg per tablet, based on the weight of the controlled-release semipermeable coating film accounting for 3% of the weight of the tablet core, the weight of the tablet core is about 194mg, and the weight of the film is about 6mg)
[0211]
[0212] Prescription of semipermeable film coating solution:
[0213] Acrylic resin 10mg
[0214] Propylene Glycol 25mg
[0215] PEG1500 75mg
[0216]Preparation process: pass new gambogic acid and auxiliary materials (other auxiliary materials except hydrogenated vegetable oil) through a 100-mesh sieve, mix well, use 95% ethanol solution to make soft materials, pass through 24 sieves for granulation, dry at 35 ° C, pass 24 Mesh sieve for granulation, add the prescribed amount of hydrogenated vegetable oil, mix evenly, compress into tablets, and control the pressure at 80N to obtain tablet cores. Dissolve acrylic resin, propylene glycol, and PEG1500 in 500 mL of acetone, and stir to make a unif...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 